References

A test in context: D-Dimer

10.1016/j.jacc.2017.09.024 · 2017 · External reference

Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19

10.1016/s0140-6736(21)01859-6 · 2021 · External reference

Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study

10.1001/jama.2014.2135 · 2014 · External reference

Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women

10.1161/01.cir.0000134965.73212.a6 · 2004 · External reference

Association of level and increase in D-Dimer with all-cause death and poor functional outcome after Ischemic Stroke or Transient Ischemic attack

10.1161/jaha.120.018600 · 2021 · External reference

Plasma D-Dimer and incident Ischemic stroke and coronary heart disease: the Atherosclerosis risk in communities study

10.1161/strokeaha.115.011035 · 2016 · External reference

D-Dimer predicts long-term cause-specific mortality, cardiovascular events, and cancer in patients with stable coronary heart disease: LIPID study

10.1161/circulationaha.117.029901 · 2018 · External reference

D-dimer as a thrombus biomarker for predicting 2-year mortality after percutaneous coronary intervention

10.1177/2040622320904302 · 2020 · External reference

Platelet function, thrombin and fibrinolytic activity in patients with heart failure

10.1093/eurheartj/14.2.205 · 1993 · External reference

Elevated D-dimer levels predict an adverse outcome in hospitalized patients with acute decompensated heart failure

10.1016/j.ijcard.2015.11.156 · 2016 · External reference

Increased D-Dimer levels predict cardiovascular mortality in patients with systolic heart failure

10.1007/s11239-011-0635-0 · 2012 · External reference

D-dimer level and long-term outcome in patients with end-stage heart failure secondary to idiopathic dilated cardiomyopathy

10.11909/j.issn.1671-5411.2019.08.005 · 2019 · External reference

Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism

10.7326/0003-4819-153-8-201010190-00009 · 2010 · External reference

D-dimer as a marker for cardiovascular and arterial thrombotic events in patients with peripheral arterial disease. A systematic review

10.1160/th13-01-0032 · 2013 · External reference

Hospitalized patients with heart failure: integrating electronic healthcare records and external outcome data (version 1.2)

10.13026/8a9e-w734 · 2020 · External reference

PhysioBank, PhysioToolkit, and PhysioNet: Components of a new research resource for complex physiologic signals

10.1161/01.cir.101.23.e215 · 2000 · External reference

Heart disease and stroke Statistics-2017 update: a report from the American Heart Association

10.1161/cir.0000000000000485 · 2017 · External reference

Evaluation of D-Dimer in the diagnosis of suspected deep-vein thrombosis

10.1056/nejmoa023153 · 2003 · External reference

D-Dimer testing in the diagnosis of cerebral vein thrombosis: a systematic review and a meta-analysis of the literature

10.1111/j.1538-7836.2012.04637.x · 2012 · External reference

D-Dimer: an overview of Hemostasis and Fibrinolysis, Assays, and clinical applications

10.1016/bs.acc.2014.12.001 · 2015 · External reference

D-Dimer and outcomes in hospitalized heart failure patients across the ejection fraction phenotypes

10.1002/ehf2.14049 · 2022 · External reference

Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome

10.1177/2047487315619733 · 2016 · External reference

D-dimer and the incidence of heart failure and mortality after acute myocardial infarction

10.1136/heartjnl-2020-316880 · 2021 · External reference

The prognostic value of admission D-Dimer level in patients with cardiogenic shock after acute myocardial infarction

10.3389/fcvm.2022.1083881 · 2022 · External reference

Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction

10.1186/s12959-015-0061-1 · 2015 · External reference

D-Dimer levels predict myocardial injury in ST-segment elevation myocardial infarction: a cardiac magnetic resonance imaging study

10.1371/journal.pone.0160955 · 2016 · External reference

Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction

10.1016/j.jacc.2017.11.024 · 2018 · External reference

D-Dimer and fibrinolysis in patients with various degrees of atherosclerosis

10.1093/eurheartj/16.1.38 · 1995 · External reference

Covid-19: the rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand factor, P-selectin and their interactions with endothelial cells, platelets and erythrocytes

10.3390/ijms21145168 · 2020 · External reference

Arterial thrombosis in heart failure

10.1016/s0140-6736(05)61124-5 · 1998 · External reference

Thromboembolism in heart failure patients in sinus rhythm: epidemiology, pathophysiology, clinical trials, and future direction

10.1016/j.jchf.2021.01.009 · 2021 · External reference

Noncardiac comorbidity clustering in heart failure: an overlooked aspect with potential therapeutic door

10.1007/s10741-020-09972-6 · 2022 · External reference